Thromboembolic and bleeding risks in edoxaban patients with pacemaker and cardiac monitoring procedures: Outcomes of the Global EMIT program

CONCLUSION/RELEVANCE: The periprocedural complication risk for edoxaban treated patients undergoing pacemaker or invasive cardiac monitoring implantation was low. This population of patients was well managed in routine practice. This article is protected by copyright. All rights reserved.PMID:34662445 | DOI:10.1111/pace.14381

Source: Pain Physician - October 18, 2021 Category: Anesthesiology Authors: Martin Unverdorben Christian von Heymann Amparao Santamaria Manish Saxena Thomas Vanassche Robert Wilkins James Jin Cathy Chen Paolo Colonna Source Type: research